SPONSOR
Chong Kun Dang Pharmaceutical
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Chong Kun Dang Pharmaceutical is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, Non-Small Cell Lung Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chong Kun Dang Pharmaceutical
How many clinical trials has Chong Kun Dang Pharmaceutical sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Chong Kun Dang Pharmaceutical, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, Non-Small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chong Kun Dang Pharmaceutical research focus on?
Chong Kun Dang Pharmaceutical clinical trials span Advanced Solid Tumors, Non-Small Cell Lung Cancer. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chong Kun Dang Pharmaceutical clinical trial?
To participate in a Chong Kun Dang Pharmaceutical trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chong Kun Dang Pharmaceutical trials with current recruitment status updated daily.
Clinical Trials by Chong Kun Dang Pharmaceutical
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology